Modelling the Survival Outcomes of Immuno-Oncology Drugs in Economic Evaluations: A Systematic Approach to Data Analysis and Extrapolation

BACKGROUND: New immuno-oncology (I-O) therapies that harness the immune system to fight cancer call for a re-examination of the traditional parametric techniques used to model survival from clinical trial data. More flexible approaches are needed to capture the characteristic I-O pattern of delayed...

Descripción completa

Detalles Bibliográficos
Autores principales: Gibson, Eddie, Koblbauer, Ian, Begum, Najida, Dranitsaris, George, Liew, Danny, McEwan, Phil, Tahami Monfared, Amir Abbas, Yuan, Yong, Juarez-Garcia, Ariadna, Tyas, David, Lees, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5684270/
https://www.ncbi.nlm.nih.gov/pubmed/28866758
http://dx.doi.org/10.1007/s40273-017-0558-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5684270/
https://www.ncbi.nlm.nih.gov/pubmed/28866758
http://dx.doi.org/10.1007/s40273-017-0558-5

Ejemplares similares